Despite universal newborn screening and scientific advances, US children continue to experience disabilities and death from sickle cell disease related causes. From 1999-2003, there were 275 deaths due to sickle cell disease among children through age 19 (USDHHS 2006). Significant variations in survival have been noted by state;these differences have not been explained fully by sociodemographic and health care system characteristics (Davis, Gergen and Moore 1997). Persistent variations in access to high quality care and public health services may contribute, but this issue has not been systematically addressed. Our study includes 2 specific aims: 1) To assess how varying capacities of public health systems influence survival of children with sickle cell disease in the US;2) To identify facilitators and barriers for developing public health infrastructure related to newborn screening and follow up for sickle cell disease For Aim 1, using a survey, we will relate organizational structures and functions of public health activities organized at the state level with sickle cell outcomes, specifically childhood mortality among states with a minimum number of sickle cell births per year. We also will explore whether variations within states in public health infrastructure are associated with varying mortality by county in selected states with many childhood sickle cell deaths.
For Aim 2, key informant interviews will enable us to identify what prompted and facilitated states to build their particular systems of care for newborn screening and follow up for sickle cell disease, barriers identified, and strategies for overcoming these barriers. The proposed project will inform efforts to promote survival among children with sickle cell disease and supports Healthy People 2010 Objectives related to newborn screening and follow-up (Objective #16-20), public health infrastructure (#23), access to programs among people with disabilities (#6-10), and public health surveillance and health promotion programs for people with disabilities and their caregivers (#6-13). This project addresses a major public health concern-how public health systems influence the health of people. We will examine how newborn screening for sickle cell disease influences survival of children with the disease. Findings from the study will inform the development of programs and policies aimed to promote the well-being of children and families with sickle cell disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HL090515-02
Application #
7843554
Study Section
Special Emphasis Panel (ZHL1)
Project Start
2009-04-23
Project End
2012-03-31
Budget Start
2009-04-23
Budget End
2010-03-31
Support Year
2
Fiscal Year
2009
Total Cost
$243,891
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Bundy, David G; Muschelli, John; Clemens, Gwendolyn D et al. (2016) Preventive Care Delivery to Young Children With Sickle Cell Disease. J Pediatr Hematol Oncol 38:294-300
Minkovitz, Cynthia S; Grason, Holly; Ruderman, Marjory et al. (2016) Newborn Screening Programs and Sickle Cell Disease: A Public Health Services and Systems Approach. Am J Prev Med 51:S39-47
Lance, Eboni I; Comi, Anne M; Johnston, Michael V et al. (2015) Risk Factors for Attention and Behavioral Issues in Pediatric Sickle Cell Disease. Clin Pediatr (Phila) 54:1087-93
Bundy, David G; Abrams, Michael T; Strouse, John J et al. (2015) Transcranial Doppler screening of Medicaid-insured children with sickle cell disease. J Pediatr 166:188-90
Lance, Eboni I; Casella, James F; Everett, Allen D et al. (2014) Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease. Proteomics Clin Appl 8:813-27
Burnett, Arthur L; Anele, Uzoma A; Trueheart, Irene N et al. (2014) Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease. Am J Med 127:664-8
Sadreameli, Sara Christina; Reller, Megan E; Bundy, David G et al. (2014) Respiratory syncytial virus and seasonal influenza cause similar illnesses in children with sickle cell disease. Pediatr Blood Cancer 61:875-8
Musicki, Biljana; Bivalacqua, Trinity J; Champion, Hunter C et al. (2014) Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis. J Sex Med 11:424-30
Lagoda, Gwen; Sezen, Sena F; Hurt, K Joseph et al. (2014) Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism. FASEB J 28:76-84
Bhatnagar, Pallav; Barron-Casella, Emily; Bean, Christopher J et al. (2013) Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease. PLoS One 8:e74193

Showing the most recent 10 out of 31 publications